This paper is a review of antiviral drug development in the pharmaceutical industry, including a compilation of current antiviral agents, a summary of major virus targets and a discussion of structure-activity relationships.
Authors: Herbert N. Prince, Ph.D., Daniel L. Prince, Ph.D., and Leon G. Smith M.D.